Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Practice Alert: China asserts ‘judicial sovereignty’ with new blocking statute

China recently enacted a law that could prevent China-based individuals and entities, including the China-based subsidiaries of non-Chinese companies, from providing certain assistance in criminal proceedings outside of China.

The law appears to block such companies, absent approval from the Chinese government, from disclosing evidence in China to criminal enforcement authorities outside of China in connection with a criminal matter.… Continue Reading

Eric Carlson: Expect more anti-corruption enforcement in China

China’s biggest government reorganization in a generation, coinciding with rapidly escalating U.S.-China trade tensions, will impact many aspects of doing business in China, including an uptick in anti-corruption enforcement.

1. “Super” enforcement agency targeting government officials is established.… Continue Reading

China FDA proposals could affect life science industry sales and promotional activities

Late last week, the China Food & Drug Administration released for public comment four draft policy circulars designed to speed approvals for innovative drugs and medical devices, permit conditional approvals for certain products where efficacy has been proven in clinical trials, further protect data exclusivity during clinical trials, allow more flexibility during clinical trials, and clarify IP rights.… Continue Reading

Eric Carlson: Take the headaches out of China investigations (Part 2)

Yesterday’s post on minimizing headaches during China investigations discussed company policies and mitigating risk under PRC privacy and state secrets laws.

We look today at IT assessments, other PRC laws, and local resources, continuing our list of steps companies can take now to minimize headaches when an investigation in China arises.… Continue Reading

Eric Carlson: Take the headaches out of China investigations (Part 1)

Any company with more than a small presence in China is likely to need to conduct an internal investigation there at some point.

While investigations in China are not wholly different than in other jurisdictions, our experience handling scores of such investigations leads us to the conclusion that companies can take certain steps in advance to minimize headaches if and when such an investigation in China is needed.… Continue Reading